Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-19-008169
Filing Date
2019-02-14
Accepted
2019-02-14 16:41:31
Documents
2
Group Members
DTMG LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G tv512338_sc13g.htm SC 13G 68136
2 EXHIBIT 99.1 tv512338_ex99-1.htm EX-99.1 3791
  Complete submission text file 0001144204-19-008169.txt   73317
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4682
Solid Biosciences Inc. (Subject) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90280 | Film No.: 19607455
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SOLID BIOSCIENCES, LLC 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address
Hayeem Gilad David (Filed by) CIK: 0001728113 (see all company filings)

Type: SC 13G